PL2657227T3 - Nowa podstawiona pochodna izochinoliny - Google Patents

Nowa podstawiona pochodna izochinoliny

Info

Publication number
PL2657227T3
PL2657227T3 PL11851146.8T PL11851146T PL2657227T3 PL 2657227 T3 PL2657227 T3 PL 2657227T3 PL 11851146 T PL11851146 T PL 11851146T PL 2657227 T3 PL2657227 T3 PL 2657227T3
Authority
PL
Poland
Prior art keywords
novel substituted
isoquinoline derivative
substituted isoquinoline
derivative
novel
Prior art date
Application number
PL11851146.8T
Other languages
English (en)
Inventor
Hiroyoshi Hidaka
Kengo Sumi
Kouichi Takahashi
Yoshihiro Inoue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2657227T3 publication Critical patent/PL2657227T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PL11851146.8T 2010-12-22 2011-12-21 Nowa podstawiona pochodna izochinoliny PL2657227T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010286445 2010-12-22

Publications (1)

Publication Number Publication Date
PL2657227T3 true PL2657227T3 (pl) 2016-09-30

Family

ID=46313995

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11851146.8T PL2657227T3 (pl) 2010-12-22 2011-12-21 Nowa podstawiona pochodna izochinoliny

Country Status (20)

Country Link
US (1) US8883792B2 (pl)
EP (1) EP2657227B1 (pl)
JP (1) JP5781093B2 (pl)
KR (1) KR101911324B1 (pl)
CN (1) CN103270024B (pl)
AU (1) AU2011345969B2 (pl)
BR (1) BR112013015604B1 (pl)
CA (1) CA2822787C (pl)
CY (1) CY1117560T1 (pl)
DK (1) DK2657227T3 (pl)
EA (1) EA022646B1 (pl)
ES (1) ES2571529T3 (pl)
HR (1) HRP20160465T1 (pl)
HU (1) HUE029976T2 (pl)
MX (1) MX2013007296A (pl)
NZ (1) NZ612336A (pl)
PL (1) PL2657227T3 (pl)
PT (1) PT2657227T (pl)
TW (1) TWI527799B (pl)
WO (1) WO2012086727A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021042126A (ja) * 2017-12-27 2021-03-18 佐藤製薬株式会社 アリールオキシ化合物
SG11202105739YA (en) * 2018-12-17 2021-07-29 D Western Therapeutics Institute Inc New form of isoquinoline sulfonamide
ES3010713T3 (en) 2018-12-18 2025-04-04 D Western Therapeutics Inst Inc Isoquinoline sulfonyl chloride acid addition salts and method of manufacture thereof
WO2020172615A1 (en) 2019-02-22 2020-08-27 Glaukos Corporation Compounds for the treatment of ocular disease
US10947196B2 (en) 2019-03-27 2021-03-16 Curasen Therapeutics, Inc. Beta adrenergic agonist and methods of using the same
EP3993878A4 (en) * 2019-07-01 2023-11-08 Curasen Therapeutics, Inc. BETA-ADRENERGIC AGONIST AND RELATED METHODS OF USE
CN110616439B (zh) * 2019-10-31 2020-06-30 安阳师范学院 电化学氧化合成4-磺酸取代异喹啉酮衍生物的方法
CN116194448A (zh) * 2020-08-31 2023-05-30 视点医疗股份有限公司 用于治疗眼科疾病的化合物和制剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169085B1 (en) 1995-03-10 2001-01-02 G. D. Searle & Company Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6667307B2 (en) 1997-12-19 2003-12-23 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5985870A (en) 1995-03-10 1999-11-16 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
JP3719609B2 (ja) 1995-12-21 2005-11-24 アルコン ラボラトリーズ,インコーポレイテッド 緑内障および眼虚血の治療のための特定のイソキノリンスルホニル化合物の使用
JP2005232175A (ja) * 2004-01-21 2005-09-02 Asahi Kasei Pharma Kk 5−置換イソキノリン医薬
US20090275099A1 (en) 2004-04-27 2009-11-05 Regents Of The University Of Michigan Methods and compositions for treating diseases and conditions associated with mitochondrial function
US20050272723A1 (en) 2004-04-27 2005-12-08 The Regents Of The University Of Michigan Methods and compositions for treating diseases and conditions associated with mitochondrial function
EP1799637A1 (en) * 2004-09-23 2007-06-27 Amgen, Inc Substituted sulfonamidopropionamides and methods of use
US7517991B2 (en) 2004-10-12 2009-04-14 Bristol-Myers Squibb Company N-sulfonylpiperidine cannabinoid receptor 1 antagonists
US8455514B2 (en) 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
CA2719907A1 (en) 2008-04-04 2009-10-08 Merck Sharp & Dohme Corp. Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
DK2315740T3 (en) 2008-07-08 2018-01-08 Catabasis Pharmaceuticals Inc Fatty Acid Acetylated Salicylates and Their Uses
WO2010126626A2 (en) 2009-05-01 2010-11-04 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
KR101732907B1 (ko) 2009-06-19 2017-05-08 가부시키가이샤 디. 웨스턴 세라퓨틱스 겡큐쇼 치환된 이소퀴놀린 유도체

Also Published As

Publication number Publication date
CN103270024B (zh) 2015-07-08
EP2657227A1 (en) 2013-10-30
ES2571529T3 (es) 2016-05-25
JP5781093B2 (ja) 2015-09-16
TWI527799B (zh) 2016-04-01
US8883792B2 (en) 2014-11-11
US20130274269A1 (en) 2013-10-17
DK2657227T3 (en) 2016-08-01
BR112013015604B1 (pt) 2021-11-03
EA201390939A1 (ru) 2013-12-30
KR20130142163A (ko) 2013-12-27
HUE029976T2 (en) 2017-04-28
CN103270024A (zh) 2013-08-28
JPWO2012086727A1 (ja) 2014-06-05
PT2657227T (pt) 2016-08-01
KR101911324B1 (ko) 2018-10-25
HK1185619A1 (en) 2014-02-21
EA022646B1 (ru) 2016-02-29
CA2822787C (en) 2018-07-17
HRP20160465T1 (hr) 2016-06-03
NZ612336A (en) 2014-05-30
TW201305112A (zh) 2013-02-01
WO2012086727A1 (ja) 2012-06-28
AU2011345969A1 (en) 2013-07-11
CA2822787A1 (en) 2012-06-28
BR112013015604A2 (pt) 2018-07-24
AU2011345969B2 (en) 2016-04-21
MX2013007296A (es) 2013-08-26
CY1117560T1 (el) 2017-04-26
EP2657227A4 (en) 2013-11-27
EP2657227B1 (en) 2016-04-27

Similar Documents

Publication Publication Date Title
AP3607A (en) Substituted imidazopyridazines
SMT201700319T1 (it) Pirrolidin-2-carbossammidi sostituite
PL2444395T3 (pl) Podstawiona pochodna izochinoliny
GB201005589D0 (en) Novel compounds
ZA201300032B (en) Tetrahydrocarboline derivative
GB201112400D0 (en) No details
PT2657227T (pt) Novo derivado de isoquinolina substituída
ZA201304430B (en) Substituted sodium-1h-pyrazole-5-olate
ZA201303887B (en) 2-carboxamide-4-piperazinyl-benzofuran derivative
IL216062A0 (en) Novel isoquinoline derivatives
SI2628733T1 (sl) Derivati acilbenzena
GB201007789D0 (en) Novel Compound
ZA201300155B (en) Substituted pyridine compound
PT2671869E (pt) Derivado de tetra-hidroisoquinolina
GB201003745D0 (en) Novel compounds ll
GB201002829D0 (en) Novel copmounds
GB201002810D0 (en) Novel compound
GB201002112D0 (en) Novel compounds
GB201002821D0 (en) Novel compounds
GB201002799D0 (en) Novel compounds
GB201002827D0 (en) Novel compounds
GB201002097D0 (en) Novel compounds
GB201002811D0 (en) Novel compounds
GB201002828D0 (en) Novel compounds
GB201000685D0 (en) Novel compounds